Janus Henderson Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.69M Sell
104,720
-142,119
-58% -$10.4M ﹤0.01% 779
2025
Q1
$13.5M Sell
246,839
-54,651
-18% -$2.99M 0.01% 644
2024
Q4
$15.2M Sell
301,490
-22,527
-7% -$1.14M 0.01% 645
2024
Q3
$15M Sell
324,017
-17,793
-5% -$823K 0.01% 622
2024
Q2
$11.1M Buy
341,810
+76,761
+29% +$2.49M 0.01% 660
2024
Q1
$6.68M Buy
265,049
+219,551
+483% +$5.53M ﹤0.01% 783
2023
Q4
$1.48M Sell
45,498
-69
-0.2% -$2.24K ﹤0.01% 1413
2023
Q3
$1.24M Buy
45,567
+21
+0% +$572 ﹤0.01% 1444
2023
Q2
$1.01M Sell
45,546
-80,254
-64% -$1.78M ﹤0.01% 1611
2023
Q1
$2.72M Sell
125,800
-17,015
-12% -$368K ﹤0.01% 1106
2022
Q4
$2.9M Sell
142,815
-711,511
-83% -$14.5M ﹤0.01% 998
2022
Q3
$21.9M Buy
854,326
+701,815
+460% +$18M 0.01% 654
2022
Q2
$3.63M Buy
152,511
+23,247
+18% +$553K ﹤0.01% 907
2022
Q1
$2.91M Sell
129,264
-47,327
-27% -$1.07M ﹤0.01% 1131
2021
Q4
$3.5M Buy
176,591
+15,249
+9% +$302K ﹤0.01% 1157
2021
Q3
$3.18M Sell
161,342
-30,276
-16% -$596K ﹤0.01% 1154
2021
Q2
$4.22M Sell
191,618
-28,740
-13% -$632K ﹤0.01% 1097
2021
Q1
$5.24M Buy
220,358
+79,693
+57% +$1.9M ﹤0.01% 1001
2020
Q4
$3.68M Buy
140,665
+20,928
+17% +$548K ﹤0.01% 1024
2020
Q3
$2.08M Buy
119,737
+21,642
+22% +$377K ﹤0.01% 1051
2020
Q2
$1.65M Buy
98,095
+78,205
+393% +$1.31M ﹤0.01% 1056
2020
Q1
$236K Sell
19,890
-46,434
-70% -$551K ﹤0.01% 1247
2019
Q4
$803K Buy
66,324
+3,758
+6% +$45.5K ﹤0.01% 1244
2019
Q3
$884K Buy
62,566
+7,874
+14% +$111K ﹤0.01% 1231
2019
Q2
$610K Sell
54,692
-1,325
-2% -$14.8K ﹤0.01% 1247
2019
Q1
$658K Buy
+56,017
New +$658K ﹤0.01% 1212